Pages that link to "Q37922476"
Jump to navigation
Jump to search
The following pages link to Immunotherapy with monomethoxypolyethylene glycol modified allergens (Q37922476):
Displaying 16 items.
- Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential (Q24657256) (← links)
- In situ imaging of honeybee (Apis mellifera) venom components from aqueous and aluminum hydroxide–adsorbed venom immunotherapy preparations (Q34079739) (← links)
- Specific tumor labeling enhanced by polyethylene glycol linkage of near infrared dyes conjugated to a chimeric anti-carcinoembryonic antigen antibody in a nude mouse model of human pancreatic cancer (Q34163904) (← links)
- Size exclusion chromatography does not require pores (Q35152445) (← links)
- Surface engineering of liposomes for stealth behavior (Q37415968) (← links)
- Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody (Q39991117) (← links)
- Modulation of allergen-specific antibody responses by T-cell-based peptide vaccine(s). Principles and potential (Q40391877) (← links)
- Novel approaches in immunotherapy (Q40694230) (← links)
- Safety considerations in assessing the role of immunotherapy in allergic disorders (Q40729285) (← links)
- Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and Applications (Q42175440) (← links)
- Glucose-binding property of pegylated concanavalin A. (Q43689074) (← links)
- Conjugates of ovalbumin and monomethoxypolyethylene glycol abolish late allergic responses and decrease IL-4 and IL-5 mRNA expression in the rat (Q44633522) (← links)
- The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know? (Q45854919) (← links)
- Accurate evaluation method of the polymer content in monomethoxy(polyethylene glycol) modified proteins based on amino acid analysis (Q68280896) (← links)
- Systemic Delivery of CRISPR/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors (Q90181590) (← links)
- Site-specific PEGylation of micro-plasmin for improved thrombolytic therapy through engineering enhanced resistance against serpin mediated inhibition (Q92374167) (← links)